Bernd Mayer

Title: Bernd Mayer: Innovator in Kidney Injury and Cancer Diagnostics

Introduction

Bernd Mayer is a distinguished inventor based in Vienna, Austria. He has made significant contributions to the fields of medical diagnostics, particularly in the areas of acute kidney injury and cancer detection. With a total of 3 patents, Mayer's work has the potential to impact patient care and treatment outcomes.

Latest Patents

Mayer's latest patents include innovative methods and tools for diagnosing health conditions. One notable invention is a method for determining the risk of acute kidney injury. This method involves assessing the levels of specific markers such as REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG in a sample. Another significant patent focuses on antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein. This invention provides antibodies for isolating and identifying epitopes of the endogenous retrovirus, which are particularly useful in the treatment and diagnosis of cancer, especially melanoma. The patent also includes diagnostic kits for detecting cancer cells and methods for cancer diagnosis using these antibodies.

Career Highlights

Throughout his career, Bernd Mayer has worked with reputable organizations, including Baxter Healthcare. His expertise in medical diagnostics has positioned him as a key player in the development of innovative solutions for critical health issues.

Collaborations

Mayer has collaborated with notable professionals in his field, including Rainer Oberbauer and Paul Perco. These collaborations have further enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Bernd Mayer's contributions to medical diagnostics through his patents demonstrate his commitment to improving healthcare outcomes. His innovative approaches to diagnosing acute kidney injury and cancer highlight the importance of research and development in the medical field.